Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
absent, acknowledged, adult, analogue, anniversary, aptamer, Archemix, arithmetic, Australian, background, bank, Biocon, biosimilar, Bulletin, capacity, caption, card, Carlo, chosen, clearance, CMC, COBRA, commented, concept, consummating, contacted, corroborated, counted, crossed, cycle, De, DeSouza, Distinguishing, dollar, Errol, error, exantide, Extra, fact, Fee, fell, fifteen, FileNo, flow, fluctuate, fluctuated, forfeiture, formally, forum, freestanding, fungible, glargine, glucagon, grantee, growing, Hong, housing, indentified, indeterminate, insight, instrument, intervening, irrelevant, issuedASC, jointly, Kong, leave, Linjeta, Linjetatm, LinjetatmDevelopment, Lintejatm, liraglutide, Lundbeck, milestone, ml, Monte, monthly, national, neuroendocrinology, neuroscience, newer, ofASC, ofFSP, ordinary, Palatin, partnership, PDUFA, peer, postdoctoral, pump, qualitative, Redeemable, reevaluated, repurchase, requisite, runway, score, simulation, sit, Souza, Souzajoined, Synaptic, Targacept, technique, toASC, Toronto, triplicate, unequivocal, unobservable, unvested, upcoming, upfront, usage, visual, worst
Removed:
aimed, annum, antidilutive, assuring, attractive, beneficially, bringing, broken, calcitonin, Cardinal, cargo, Catalent, cell, clamp, coincide, comparison, complexed, conjunction, continuation, databank, delicate, destruction, destructive, digestive, dose, drastically, employing, entrenchment, equivalent, examine, exerted, expedited, expend, expertise, extensively, fast, father, FDAAA, fourteen, gained, gastrointestinal, Generex, GIR, GlaxoSmithKline, hydrogen, improving, influence, infused, infusion, inhibited, intention, interaction, irritation, jurisdiction, largely, LLP, lost, lump, mandate, mask, mimicking, molecular, monitored, nasal, Nasally, orally, organization, parathyroid, penetration, Pharma, plasma, plc, Pohl, poorly, preclinicalin, prepare, PTS, reach, reached, reaching, reconciliation, Reding, reformulate, reformulating, registry, reinterpreted, repeated, repel, resignation, resigned, restated, reversible, revised, Roderike, role, route, Scott, separation, significance, sparing, Squibb, stabilize, stomach, studied, subcutaneously, suitable, suited, sum, surface, swallowed, tongue, tract, underserved, unique, unpleasant, unpredictable, unstable, variable, vitroand, volunteer, Ware, weak, Weisman, world
Filing tables
Filing exhibits
Related press release
ALBO similar filings
Filing view
External links
Exhibit 10.23
BASE SALARIES OF NAMED EXECUTIVE OFFICERS OF THE REGISTRANT
The following are the base salaries (on an annual basis) of the named executive officers of the Company:
| Name and Title | Base Salary(1) | |||
| Errol De Souza President and Chief Executive Officer | $ | 450,000 | ||
| Solomon S. Steiner Chief Scientific Officer | $ | 400,000 | ||
| Gerard J. Michel Chief Financial Officer, Vice President Corporate Development and Treasurer | $ | 317,000 | ||
| Alan Krasnser Chief Medical Officer | $ | 312,000 | ||
| Paul Bavier General Counsel and Secretary | $ | 210,000 | ||
| (1) | Base salaries effective March 31, 2010 for CEO and CSO, and December 1, 2009 for other named executive officers. |